The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations

Ryan, 2004, Crohn's disease patients who quit smoking have a reduced risk of reoperation for recurrence, Am J Surg, 187, 219, 10.1016/j.amjsurg.2003.11.007

Onali, 2009, Frequency, pattern, and risk factors of postoperative recurrence of Crohn's disease after resection different from ileo-colonic, J Gastrointest Surg, 13, 246, 10.1007/s11605-008-0726-1

Sachar, 2009, Recurrence patterns after first resection for stricturing or penetrating Crohn's disease, Inflamm Bowel Dis, 15, 1071, 10.1002/ibd.20872

Hofer, 2001, The impact of clinical types of disease manifestation on the risk of early postoperative recurrence in Crohn's disease, Hepatogastroenterology, 48, 152

Bernell, 2000, Risk factors for surgery and recurrence in 907 patients with primary ileocaecal Crohn's disease, Br J Surg, 87, 1697, 10.1046/j.1365-2168.2000.01589.x

Welsch, 2007, Early re-laparotomy for post-operative complications is a significant risk factor for recurrence after ileocaecal resection for Crohn's disease, Int J Colorectal Dis, 22, 1043, 10.1007/s00384-007-0309-8

Caprilli, 1996, Prognostic factors for postoperative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC), Dis Colon Rectum, 39, 335, 10.1007/BF02049478

Renna, 2008, Meta-analysis of the placebo rates of clinical relapse and severe endoscopic recurrence in postoperative Crohn's disease, Gastroenterology, 135, 1500, 10.1053/j.gastro.2008.07.066

Botti, 2003, The minimal bowel resection in Crohn's disease: analysis of prognostic factors on the surgical recurrence, Ann Ital Chir, 74, 627

Fazio, 1999, Recurrent Crohn's disease and resection margins: bigger is not better, Adv Surg, 32, 135

Athanasiadis, 2007, Recovery rates and functional results after repair for rectovaginal fistula in Crohn's disease: a comparison of different techniques, Int J Colorectal Dis, 22, 1051, 10.1007/s00384-007-0294-y

Sampietro, 2009, Prospective study of long-term results and prognostic factors after conservative surgery for small bowel Crohn's disease, Clin Gastroenterol Hepatol, 7, 183, 10.1016/j.cgh.2008.10.008

Yamamoto, 2007, Safety and efficacy of strictureplasty for Crohn's disease: a systematic review and meta-analysis, Dis Colon Rectum, 50, 1968, 10.1007/s10350-007-0279-5

Viscido, 1999, Crohn's disease activity index is inaccurate to detect the post-operative recurrence in Crohn's disease. A GISC study, Ital J Gastroenterol Hepatol, 31, 274

Lamb CA, Mohiuddin MK, Gicquel J, Neely D, Bergin FG, Hanson JM, Mansfield JC. Faecal calprotectin or lactoferrin can identify postoperative recurrence in Crohn's disease. Br J Surg 2009 Apr 21. [Electronic publication ahead of print].

Rutgeerts, 1984, Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery, Gut, 25, 665, 10.1136/gut.25.6.665

Whelan, 1985, Recurrence after surgery in Crohn's disease, Gastroenterology, 88, 1826, 10.1016/0016-5085(85)90007-1

Tytgat, 1988, Endoscopic lesions in Crohn's disease early after ileocecal resection, Endoscopy, 20, 260, 10.1055/s-2007-1018188

Rutgeerts, 1990, Predictability of the postoperative course of Crohn's disease, Gastroenterology, 99, 956, 10.1016/0016-5085(90)90613-6

Olaison, 1992, Natural course of Crohn's disease after ileocolic resection: endoscopically visualized ileal ulcers preceding the symptoms, Gut, 33, 331, 10.1136/gut.33.3.331

Caprilli, 1994, Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of post-operative recurrence of CD, Aliment Pharmacol Ther, 8, 35, 10.1111/j.1365-2036.1994.tb00158.x

Maccioni, 2002, MRI evaluation of Crohn's disease of the small and large bowel with the use of negative superparamagnetic oral contrast agents, Abdom Imaging, 27, 384, 10.1007/s00261-001-0119-3

Parente, 2004, Modern imaging of Crohn's disease using bowel ultrasound, Inflamm Bowel Dis, 10, 452, 10.1097/00054725-200407000-00022

Castiglione, 2008, Oral contrast-enhanced sonography for the diagnosis and grading of postsurgical recurrence of Crohn's disease, Inflamm Bowel Dis, 14, 1240, 10.1002/ibd.20469

Biancone, 2007, Wireless capsule endoscopy and small intestine contrast ultrasonography in recurrence of Crohn's disease, Inflamm Bowel Dis, 13, 1256, 10.1002/ibd.20199

Pons Beltran, 2007, Evaluation of postsurgical recurrence in Crohn's disease: a new indication for capsule endoscopy?, Gastrointest Endosc, 66, 533, 10.1016/j.gie.2006.12.059

Kennedy, 2008, Do patients consider postoperative maintenance therapy for Crohn's disease worthwhile?, Inflamm Bowel Dis, 14, 224, 10.1002/ibd.20300

Caprilli, 1998, In favour of prophylactic treatment for post-operative recurrence in Crohn's disease, Ital J Gastroenterol Hepatol, 30, 219

Breslin, 1998, The case against routine post-operative therapy for prevention of recurrence in Crohn's disease, Ital J Gastroenterol Hepatol, 30, 226

McLeod, 1995, Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease, Gastroenterology, 109, 404, 10.1016/0016-5085(95)90327-5

Brignola, 1995, Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease, Gastroenterology, 108, 345, 10.1016/0016-5085(95)90059-4

Lochs, 2000, Prophylaxis of post-operative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI, Gastroenterology, 118, 264, 10.1016/S0016-5085(00)70208-3

Cottone, 2000, Mesalamine and relapse prevention in Crohn's disease, Gastroenterology, 118, 597, 10.1053/gast.2000.16153

Caprilli, 2003, Two mesalazine regimens in the prevention of the post-operative recurrence of Crohn's disease: a pragmatic, double-blind, randomized controlled trial, Aliment Pharmacol Ther, 17, 517, 10.1046/j.1365-2036.2003.01462.x

Cammà, 2002, Mesalamine in the prevention of clinical and endoscopic post-operative recurrence of Crohn's disease: a meta-analysis, Dig Liver Dis, 34, A86, 10.1016/S1590-8658(02)90327-0

Florent, 1996, Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease, Eur J Gastroenterol Hepatol, 8, 229, 10.1097/00042737-199603000-00008

Rutgeerts, 1995, Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection, Gastroenterology, 108, 1617, 10.1016/0016-5085(95)90121-3

Rutgeerts, 2005, Ornidazole for prophylaxis of post-operative Crohn's disease: a randomized, double blind, placebo-controlled trial, Gastroenterology, 128, 856, 10.1053/j.gastro.2005.01.010

Hanauer, 2004, Post-operative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine or placebo: a 2year trial, Gastroenterology, 127, 723, 10.1053/j.gastro.2004.06.002

Ardizzone, 2004, Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease, Gastroenterology, 127, 730, 10.1053/j.gastro.2004.06.051

Herfarth, 2006, Adverse events in clinical trials with azathioprine and mesalamine for prevention of postoperative recurrence of Crohn's disease, Gut, 55, 1525

D'Haens, 2008, Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: a controlled randomized trial, Gastroenterology, 135, 1123, 10.1053/j.gastro.2008.07.010

Peyrin-Biroulet, 2009, Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn's disease: a meta-analysis, Am J Gastroenterol, 104, 2089, 10.1038/ajg.2009.301

Renna, 2008, Meta-analysis of the placebo rates of clinical relapse and severe endoscopic recurrence in postoperative Crohn's disease, Gastroenterology, 135, 1500, 10.1053/j.gastro.2008.07.066

Reinisch, 2008, A double-blind, double-dummy, randomized, controlled, multicenter trial on the efficacy and safety of azathioprine vs mesalamine for prevention of clinical relapses in Crohn's disease patients with postoperative moderate or severe endoscopic recurrence, Gastroenterology, 134, A70, 10.1016/S0016-5085(08)60328-5

Regueiro, 2009, Infliximab prevents Crohn's disease recurrence after ileal resection, Gastroenterology, 136, 441, 10.1053/j.gastro.2008.10.051

Prantera, 2002, Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG, Gut, 51, 405, 10.1136/gut.51.3.405

Marteau, 2006, Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial, Gut., 55, 842, 10.1136/gut.2005.076604

Van Gossum, 2007, Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after lleo-caecal resection, Inflamm Bowel Dis, 13, 135, 10.1002/ibd.20063

Chermesh, 2007, Failure of Synbiotic 2000 to prevent postoperative recurrence of Crohn's disease, Dig Dis Sci, 52, 385, 10.1007/s10620-006-9549-7

Campieri M, Rizzello F, Venturi A, et al. Combination of antibiotic and probiotic treatment is efficacious in prophylaxis of post-operative recurrence in Crohn’s disease: a randomized controlled study vs mesalamine. Gastroenterology 2000;118:A781.

Colombel, 2001, Interleukin 10 (Tenovil) in the prevention of post-operative recurrence of Crohn's disease, Gut, 49, 42, 10.1136/gut.49.1.42

Keighley, 1986, Current status and influence of operation on perianal Crohn's disease, Int J Colorectal Dis, 1, 104, 10.1007/BF01648416

Hellers, 1980, Occurrence and outcome after primary treatment of anal fistulae in Crohn's disease, Gut, 21, 525, 10.1136/gut.21.6.525

Schwartz, 2002, The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota, Gastroenterology, 122, 875, 10.1053/gast.2002.32362

Tang, 2006, Are perineal and luminal fistulas associated in Crohn's disease? A population-based study, Clin Gastroenterol Hepatol, 4, 1130, 10.1016/j.cgh.2006.06.021

Haggett, 1995, Pelvic and perineal complications of Crohn's disease: assessment using magnetic resonance imaging, Gut, 36, 407, 10.1136/gut.36.3.407

Skalej, 1993, Magnetic resonance imaging in perianal Crohn's disease, Dtsch Med Wochenschr, 118, 1791, 10.1055/s-2008-1059515

Koelbel, 1989, Diagnosis of fistulae and sinus tracts in patients with Crohn disease: value of MR imaging, Am J Roentgenol, 152, 999, 10.2214/ajr.152.5.999

van Bodegraven, 2002, Endosonographic evidence of persistence of Crohn's disease-associated fistulas after infliximab treatment, irrespective of clinical response, Dis Colon Rectum, 45, 39, 10.1007/s10350-004-6111-6

Sloots, 2001, Assessment and classification of fistula-in-ano in patients with Crohn's disease by hydrogen peroxide enhanced transanal ultrasound, Int J Colorectal Dis, 16, 292, 10.1007/s003840100308

Orsoni, 1999, Prospective comparison of endosonography, magnetic resonance imaging and surgical findings in anorectal fistula and abscess complicating Crohn's disease, Br J Surg, 86, 360, 10.1046/j.1365-2168.1999.01020.x

Buchanan, 2004, Clinical examination, endosonography, and MR imaging in preoperativ assessment of fistula in Ano: comparison with outcome-based reference standard, Radiology, 233, 674, 10.1148/radiol.2333031724

Halligan, 2006, Imaging of fistula in Ano, Radiology, 239, 18, 10.1148/radiol.2391041043

Parks, 1976, A classification of fistula-in-ano, Br J Surg, 63, 1, 10.1002/bjs.1800630102

Bell, 2003, The clinical course of fistulating Crohn's disease, Aliment Pharmacol Ther, 17, 1145, 10.1046/j.1365-2036.2003.01561.x

Berstein, 1980, Healing of perineal Crohn's disease with metronidazole, Gastroenterology, 79, 357, 10.1016/0016-5085(80)90155-9

Brandt, 1982, Metronidazole therapy for perineal Crohn's disease: a follow-up study, Gastroenterology, 83, 383, 10.1016/S0016-5085(82)80332-6

Jakobovits, 1984, Metronidazole therapy for Crohn's disease and associated fistulae, Am J Gastroenterol, 79, 533

Solomon, 1993, Combination ciprofloxacin and metronidazole in severe perianal Crohn's disease, Can J Gastroenterol, 7, 571, 10.1155/1993/610272

Thia, 2009, Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study, Inflamm Bowel Dis, 15, 17, 10.1002/ibd.20608

Pearson, 1995, Azathioprine and 6-mercaptopurine in Crohn's disease. A meta-analysis, Ann Intern Med, 122, 132, 10.7326/0003-4819-123-2-199507150-00009

Korelitz, 1993, Long-term experience with 6-mercaptopurine in the treatment of Crohn's disease, Am J Gastroenterol, 88, 1198

Present, 1999, Infliximab for the treatment of fistulas in patients with Crohn's disease, N Engl J Med, 340, 1398, 10.1056/NEJM199905063401804

Sands, 2004, Infliximab maintenance therapy for fistulizing Crohn's disease, N Engl J Med, 350, 876, 10.1056/NEJMoa030815

Sands, 2004, Long-term treatment of rectovaginal fistulas in Crohn's disease: response to infliximab in the ACCENT II Study, Clin Gastroenterol Hepatol, 2, 912, 10.1016/S1542-3565(04)00414-8

Lichtenstein, 2005, Infliximab maintenance treatment reduces hospitalizations, surgeries and procedures in fistulizing Crohn's disease, Gastroenterology, 128, 862, 10.1053/j.gastro.2005.01.048

Farrell, 2000, Clinical experience with infliximab therapy in 100 patients with Crohn's disease, Am J Gastroenterol, 95, 3490, 10.1111/j.1572-0241.2000.03366.x

Ricart, 2001, Infliximab for Crohn's disease in clinical practice at the Mayo Clinic: the first 100 patients, Am J Gastroenterol, 96, 722, 10.1111/j.1572-0241.2001.03612.x

Hanauer, 2006, A randomized, double-blind, placebo-controlled trial of the human anti-TNF—a monoclonal antibody adalimumab for the induction of remission in patients with moderate to severely active Crohn's disease, Gastroenterology, 130, 323, 10.1053/j.gastro.2005.11.030

Sandborn, 2007, Adalimumab induction therapy for Crohn's disease previously treated with infliximab, Ann Intern Med, 146, 829, 10.7326/0003-4819-146-12-200706190-00159

Colombel, 2007, Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial, Gastroenterology, 132, 52, 10.1053/j.gastro.2006.11.041

Colombel, 2009, Adalimumab for the treatment of fistulas in patients with Crohn's disease, Gut, 58, 940, 10.1136/gut.2008.159251

Hinojosa, 2007, Aliment Pharmacol Ther, 25, 409, 10.1111/j.1365-2036.2006.03232.x

Schreiber, 2007, Maintenance therapy with certolizumab pegol for Crohn's disease, N Engl J Med, 357, 239, 10.1056/NEJMoa062897

Sandborn, 2007, Certolizumab pegol for the treatment of Crohn's disease, N Engl J Med, 357, 228, 10.1056/NEJMoa067594

Sandborn WJ. A critical review of cyclosporine therapy in inflammatory bowel disease. Inflam Bowel Dis 1995;1:48−63.

Egan, 1998, Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine, Am J Gastroenterol, 93, 442, 10.1111/j.1572-0241.1998.00442.x

Sandborn, 1997, Preliminary report on the use of oral tacrolimus (FK506) in the treatment of complicated proximal small bowel and fistulizing Crohn's disease, Am J Gastroenterol, 92, 876

Fellermann, 1998, Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506), Am J Gastroenterol, 93, 1860, 10.1111/j.1572-0241.1998.539_g.x

Lowry, 1999, Combination therapy with oral tacrolimus (FK506) and azathioprine or 6-mercaptopurine for treatment-refractory Crohn's disease perianal fistulae, Inflamm Bowel Dis, 5, 239, 10.1097/00054725-199911000-00001

Ierardi, 2000, Oral tacrolimus (FK 506) in Crohn's disease complicated by fistulae of the perineum, J Clin Gastroenterol, 30, 200, 10.1097/00004836-200003000-00015

Sandborn, 2003, Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial, Gastroenterology, 125, 380, 10.1016/S0016-5085(03)00877-1

Sandborn, 2003, AGA technical review on perianal Crohn's disease, Gastroenterology, 125, 1508, 10.1016/j.gastro.2003.08.025

Poggioli, 2005, Local injection of infliximab for the treatment of perianal Crohn's disease, Dis Colon Rectum, 48, 768, 10.1007/s10350-004-0832-4

Asteria, 2006, Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study, Scand J Gastroenterol, 41, 1064, 10.1080/00365520600609941

Gaertner, 2007, Does infliximab infusion impact results of operative treatment for Crohn's perianal fistulas?, Dis Colon Rectum, 50, 1754, 10.1007/s10350-007-9077-3

Hyder, 2006, Fisulating anal Crohn's disease: results of combined surgical and infliximab treatment, Dis Colon Rectum, 49, 1837, 10.1007/s10350-006-0656-5

Topstad, 2003, Combined seton placement, infliximab infusion, and maintenance immunosuppressives improving healing rate in fistulising anorectal Crohn's disease. A single center experience, Dis Colon Rectum, 46, 577, 10.1007/s10350-004-6611-4

van der Hagen, 2005, Anti-TNF-alpha (infliximab) used as induction treatment in case of active proctitis in a multistep strategy followed by definitive surgery of complex anal fistulas in Crohn's disease: a preliminary report, Dis Colon Rectum, 48, 758, 10.1007/s10350-004-0828-0

Wexner, 2008, Gracilis muscle interposition for the treatment of rectourethral, rectovaginal, and pouch-vaginal fistulas: results in 53 patients, Ann Surg, 248, 39, 10.1097/SLA.0b013e31817d077d

Fürst, 2008, Gracilis transposition for repair of recurrent anovaginal and rectovaginal fistulas in Crohn's disease, Int J Colorectal Dis, 23, 349, 10.1007/s00384-007-0413-9

Askling, 1999, Incidence of paediatric Crohn's disease in Stockholm, Sweden, Lancet, 354, 1179, 10.1016/S0140-6736(99)02625-2

Armitage, 2001, Increasing incidence of both juvenile-onset Crohn's disease and ulcerative colitis in Scotland, Eur J Gastroenterol Hepatol, 13, 1439, 10.1097/00042737-200112000-00007

Sawczenko, 2001, Prospective survey of childhood inflammatory bowel disease in the British Isles, Lancet, 357, 1093, 10.1016/S0140-6736(00)04309-9

Urne, 2002, Chronic inflammatory bowel disease in children. An epidemiological study from eastern Denmark 1998–2000, Ugeskr Laeger, 164, 5810

Hildebrand, 2003, Changing pattern of paediatric inflammatory bowel disease in northern Stockholm 1990–2001, Gut, 52, 1432, 10.1136/gut.52.10.1432

Kolek, 2004, The incidence of inflammatory bowel disease is increasing among children 15years old and younger in the Czech Republic, J Pediatr Gastroenterol Nutr, 38, 362, 10.1097/00005176-200403000-00028

Tsironi, 2004, Incidence of inflammatory bowel disease is rising and abdominal tuberculosis is falling in Bangladeshis in East London, United Kingdom, Am J Gastroenterol, 99, 1749, 10.1111/j.1572-0241.2004.30445.x

Turunen, 2006, Incidence of inflammatory bowel disease in Finnish children, 1987–2003, Inflamm Bowel Dis., 12, 677, 10.1097/00054725-200608000-00002

Castro, 2008, Inflammatory bowel disease in children and adolescents in Italy: data from the pediatric national IBD register (1996–2003), Inflamm Bowel Dis., 14, 1246, 10.1002/ibd.20470

Auvin, 2005, Incidence, clinical presentation and location at diagnosis of pediatric inflammatory bowel disease: a prospective population-based study in northern France (1988–1999), J Pediatr Gastroenterol Nutr, 41, 49, 10.1097/01.MPG.0000162479.74277.86

Cannioto, 2009, IBD and IBD mimicking enterocolitis in children younger than 2years of age, Eur J Pediatr, 168, 149, 10.1007/s00431-008-0721-2

Huang, 2006, Gastrointestinal manifestations of chronic granulomatous disease, Colorectal Dis, 8, 637, 10.1111/j.1463-1318.2006.01030.x

Van Limbergen, 2008, Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease, Gastroenterology, 135, 1038, 10.1053/j.gastro.2008.06.081

Vernier-Massouille, 2008, Natural history of pediatric Crohn's disease: a population-based cohort study, Gastroenterology, 135, 1038, 10.1053/j.gastro.2008.06.079

Motil, 1993, Growth failure in children with inflammatory bowel disease: a prospective study, Gastroenterology, 105, 681, 10.1016/0016-5085(93)90883-E

Sawczenko, 2003, Presenting features of inflammatory bowel disease in Great Britain and Ireland, Arch Dis Child, 88, 995, 10.1136/adc.88.11.995

Heuschkel, 2008, Guidelines for management of growth failure in childhood inflammatory bowel disease, Inflamm Bowel Dis, 14, 839, 10.1002/ibd.20378

Mackner, 2005, Long term psychosocial outcomes reported by children and adolescents with inflammatory bowel disease, Am J Gastroenterology, 100, 1386, 10.1111/j.1572-0241.2005.41428.x

Mackner, 2006, Brief report: psychosocial adjustment in adolescents with inflammatory bowel disease, J Paediatr Psychol, 31, 281, 10.1093/jpepsy/jsj023

Loonen, 2002, Quality of life in paediatric inflammatory bowel disease measured by a generic and a disease specific questionnaire, Acta Paediatr, 91, 3348, 10.1111/j.1651-2227.2002.tb01727.x

De Boer, 2005, Health related quality of life and psychosocial functioning of adolescents with inflammatory bowel disease, Inflamm Bowel Dis, 11, 400, 10.1097/01.MIB.0000164024.10848.0a

Caprilli, 2006, European evidence based consensus on the diagnosis and management of Crohn's disease: Special situations, Gut, 55, i36, 10.1136/gut.2005.081950c

Escher, 2005, Inflammatory bowel disease in children and adolescents. Recommendations for diagnosis: the Porto criteria. Medical position paper: IBD working group of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN), J Pediatr Gastroenterol Nutr, 41, 1, 10.1097/01.MPG.0000163736.30261.82

Weinstein, 2003, Age and family history at presentation of pediatric inflammatory bowel disease, J Pediatr Gastroenterol Nutr, 37, 609, 10.1097/00005176-200311000-00020

Mack, 2007, Laboratory values for children with newly diagnosed inflammatory bowel disease, Pediatrics, 119, 1113, 10.1542/peds.2006-1865

Bunn, 2001, Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease, J Pediatr Gastroenterol Nutr, 32, 171, 10.1097/00005176-200102000-00015

Bunn, 2001, Fecal calprotectin: validation as a non-invasive measure of bowel inflammation in childhood inflammatory bowel disease, J Pediatr Gastroenterol Nutr, 33, 14, 10.1097/00005176-200107000-00003

Von Roon, 2007, Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy, Am J Gastroenterol, 102, 803, 10.1111/j.1572-0241.2007.01126.x

Fagerberg, 2005, Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms, J Pediatr Gastroenterol Nutr, 40, 450, 10.1097/01.MPG.0000154657.08994.94

Berni Canani, 2004, Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice, Dig Liver Dis, 36, 467, 10.1016/j.dld.2004.02.009

Walker, 2007, Fecal lactoferrin is a sensitive and specific marker of disease activity in children and young adults with inflammatory bowel disease, J Pediatr Gastroenterol Nutr, 44, 414, 10.1097/MPG.0b013e3180308d8e

Desai, 2007, Review article: biological activity markers in inflammatory bowel disease, Aliment Pharmacol Ther, 25, 247, 10.1111/j.1365-2036.2006.03184.x

Quail, 2009, Fecal calprotectin complements routine laboratory investigations in diagnosing childhood inflammatory bowel disease, Inflamm Bowel Dis., 15, 756, 10.1002/ibd.20820

Chong, 1985, Histological diagnosis of chronic inflammatory bowel disease in childhood, Gut, 26, 55, 10.1136/gut.26.1.55

Holmquist, 1988, The diagnostic value of colonoscopy compared with rectosigmoidoscopy in children and adolescents with symptoms of chronic inflammatory bowel disease of the colon, Scand J Gastroenterol, 23, 577, 10.3109/00365528809093915

Cameron, 1991, Upper and lower gastrointestinal endoscopy in children and adolescents with Crohn's disease: a prospective study, J Gastroenterol Hepatol, 6, 355, 10.1111/j.1440-1746.1991.tb00870.x

Escher, 2002, Value of rectosigmoidoscopy with biopsies for diagnosis of inflammatory bowel disease in children, Inflamm Bowel Dis, 8, 16, 10.1097/00054725-200201000-00003

Batres, 2002, Terminal ileum intubation in pediatric colonoscopy and diagnostic value of conventional small bowel contrast radiography in pediatric inflammatory bowel disease, J Pediatr Gastroenterol Nutr, 35, 320, 10.1097/00005176-200209000-00015

Mashako, 1989, Crohn's disease lesions in the upper gastrointestinal tract: correlation between clinical, radiological, endoscopic, and histological features in adolescents and children, J Pediatr Gastroenterol Nutr, 8, 442, 10.1097/00005176-198905000-00004

Abdullah, 2002, The role of esophagogastroduodenoscopy in the initial evaluation of childhood inflammatory bowel disease: a 7-year study, J Pediatr Gastroenterol Nutr, 35, 636, 10.1097/00005176-200211000-00009

Sharif, 2002, Focally enhanced gastritis in children with Crohn's disease and ulcerative colitis, Am J Gastroenterol, 97, 1415, 10.1111/j.1572-0241.2002.05785.x

Castellaneta, 2004, Diagnostic role of upper gastrointestinal endoscopy in pediatric inflammatory bowel disease, J Pediatr Gastroenterol Nutr, 39, 257, 10.1097/00005176-200409000-00006

Dillon, 1998, Colonoscopy under general anesthesia in children, Pediatrics, 102, 381, 10.1542/peds.102.2.381

Wengrower, 2004, Complicated endoscopic pediatric procedures using deep sedation and general anesthesia are safe in the endoscopy suite, Scand J Gastroenterol, 39, 283, 10.1080/00365520310008467

Lipson, 1990, Barium studies and ileoscopy compared in children with suspected Crohn's disease, Clin Radiol, 41, 5, 10.1016/S0009-9260(05)80922-5

Halligan, 1995, The role of small bowel radiology in the diagnosis and management of Crohn's disease, Acta Paediatr, 84, 1375, 10.1111/j.1651-2227.1995.tb13572.x

Desmond, 2008, Crohn's disease: factors associated with exposure to high levels of diagnostic radiation, Gut, 57, 1524, 10.1136/gut.2008.151415

Gaca, 2008, Radiation doses from small-bowel follow-through and abdomen/pelvis MDCT in pediatric Crohn disease, Pediatr Radiol, 38, 285, 10.1007/s00247-007-0702-z

Laghi, 2003, Contrast enhanced magnetic resonance imaging of the terminal ileum in children with Crohn's disease, Gut, 52, 393, 10.1136/gut.52.3.393

Darbari, 2004, Gadolinium-enhanced magnetic resonance imaging: a useful radiological tool in diagnosing pediatric IBD, Inflamm Bowel Dis, 10, 67, 10.1097/00054725-200403000-00001

Pilleul, 2005, Magnetic resonance imaging in Crohn's disease, Gastroenterol Clin Biol, 29, 803, 10.1016/S0399-8320(05)86351-1

Essary, 2007, Pelvic MRI in children with Crohn disease and suspected perianal involvement, Pediatr Radiol, 37, 201, 10.1007/s00247-006-0372-2

Scholbach, 2004, Dynamic colour Doppler sonography of intestinal wall in patients with Crohn disease compared with healthy subjects, J Pediatr Gastroenterol Nutr., 39, 524, 10.1097/00005176-200411000-00014

Mann, 2008, Inflammatory bowel disease: imaging of the pediatric patient, Semin Roentgenol, 43, 29, 10.1053/j.ro.2007.08.005

Albert, 2005, Diagnosis of small bowel Crohn's disease: a prospective comparison of capsule endoscopy with magnetic resonance imaging and fluoroscopic enteroclysis, Gut, 54, 1721, 10.1136/gut.2005.069427

Triester, 2006, A meta-analysis of the yield of capsule endoscopy compared to other diagnostic modalities in patients with non-stricturing small bowel Crohn's disease, Am J Gastroenterol, 101, 954, 10.1111/j.1572-0241.2006.00506.x

Thomson, 2007, Wireless capsule endoscopy in children: a study to assess diagnostic yield in small bowel disease in paediatric patients, J Pediatr Gastroenterol Nutr, 44, 192, 10.1097/01.mpg.0000252196.91707.ff

Boureille, 2009, Role of small bowel endoscopy in the management of patients with IBD: an international OMED-ECCO Consensus, Endoscopy, 41, 618, 10.1055/s-0029-1214790

De Ángelis, 2007, Wireless capsule endoscopy for pediatric small-bowel disease, Am J Gastroenterol, 102, 1749, 10.1111/j.1572-0241.2007.01209.x

Moy, 2007, Wireless capsule endoscopy in the pediatric age group: experience and complications, J Pediatr Gastroenterol Nutr, 44, 516, 10.1097/MPG.0b013e3180335548

Anato, 2007, Clinical application and diagnostic yield of wireless capsule endoscopy in children, J Laparoendosc Adv Surg Tech, Part A, 17, 364, 10.1089/lap.2006.0114

Fritscher-Ravens A, Scherbakov P, Bufler P et al. The Feasibility of wireless capsule endoscopy in detecting small intestinal pathology in children under the age of 8years — Multicenter European Study. Gut 2009 Nov;58(11):1467−72

Dziechciarz, 2007, Meta-analysis: enteral nutrition in active Crohn's disease in children, Aliment Pharmacol Ther, 26, 795, 10.1111/j.1365-2036.2007.03431.x

Zachos, 2007, Enteral nutritional therapy for induction of remission in Crohn's disease, Cochrane Database Syst Rev, 24, CD000542

Newby, 2005, Interventions for growth failure in childhood Crohn's disease, Cochrane Database Syst Rev, 20, CD003873

Shamir, 2007, Growth retardation in pediatric Crohn's disease: pathogenesis and interventions, Inflamm Bowel Dis, 13, 620, 10.1002/ibd.20115

Heuschkel, 2000, Enteral nutrition and corticosteroids in the treatment of acute Crohn's disease in children, J Pediatr Gastroenterol Nutr, 31, 8, 10.1097/00005176-200007000-00005

Afzal, 2005, Colonic Crohn's disease in children does not respond well to treatment with enteral nutrition if the ileum is not involved, Dig Dis Sci, 50, 1471, 10.1007/s10620-005-2864-6

Day, 2008, Systematic review: nutritional therapy in paediatric Crohn's disease, Aliment Pharmacol Ther, 27, 293, 10.1111/j.1365-2036.2007.03578.x

Johnson, 2006, Treatment of active Crohn's disease in children using partial enteral nutrition with liquid formula: a randomised controlled trial, Gut, 55, 356, 10.1136/gut.2004.062554

Benchimol EI, Seow CH, Steinhart AH, Griffiths AM. Traditional corticosteroids for induction of remission in Crohn's disease. Cochrane Database of Systematic Reviews 2008, Issue 2. Art. No.:CD006792. doi:10.1002/14651858. CD006792.

Tung, 2006, A population-based study of the frequency of corticosteroid resistance and dependence in pediatric patients with Crohn's disease and ulcerative colitis, Inflamm Bowel Dis, 12, 1093, 10.1097/01.mib.0000235835.32176.85

Markowitz, 2006, Corticosteroid therapy in the age of infliximab: acute and 1-year outcomes in newly diagnosed children with Crohn's disease, Clinical Gastroenterol Hepatol, 4, 1124, 10.1016/j.cgh.2006.05.011

Vihinen, 2008, Circulating glucocorticoid bioactivity during peroral treatment in children and adolescents with inflammatory bowel disease, J Clin Gastroenterol, 42, 1017, 10.1097/MCG.0b013e3180ca9585

Levine, 2002, Evaluation of oral budesonide for treatment of mild and moderate exacerbations of Crohn's disease in children, J Pediatr, 140, 75, 10.1067/mpd.2002.119992

Levine, 2003, A comparison of budesonide and prednisone for the treatment of active pediatric Crohn disease, J Pediatr Gastroenterol Nutr, 36, 248, 10.1097/00005176-200302000-00017

Escher, 2004, Budesonide versus prednisolone for the treatment of active Crohn's disease in children: a randomized, double-blind, controlled, multicentre trial, Eur J Gastroenterol Hepatol, 16, 47, 10.1097/00042737-200401000-00008

Dilger, 2006, Pharmacokinetics and pharmacodynamic action of budesonide in children with Crohn's disease, Aliment Pharmacol Ther, 23, 387, 10.1111/j.1365-2036.2006.02771.x

Benchimol E, Seow C, Otley A, Steinhart AH.Budesonide for maintenance of remission in Crohn's disease — a systematic review and meta-analysis for the Cochrane Collaboration.

Bousvaros, 2005, A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease, Inflamm Bowel Dis, 11, 833, 10.1097/01.MIB.0000175905.00212.2c

Markowitz, 2000, A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease, Gastroenterology, 119, 895, 10.1053/gast.2000.18144

Mack, 1998, Methotrexate in patients with Crohn's disease after 6-mercaptopurine, J Pediatr, 132, 830, 10.1016/S0022-3476(98)70313-0

Uhlen, 2006, Efficacy of methotrexate in pediatric Crohn's disease: a French multicenter study, Inflamm Bowel Dis, 12, 1053, 10.1097/01.mib.0000235103.47280.bb

Ravikumara, 2007, Role of methotrexate in the management of Crohn's disease, J Pediatr Gastroenterol Nutr, 44, 427, 10.1097/MPG.0b013e3180320689

Turner, 2007, Methotrexate following unsuccessful thiopurine therapy in pediatric Crohn's disease, Am J Gastroenterol, 102, 2804, 10.1111/j.1572-0241.2007.01474.x

Lazzerini, 2007, Efficacy and safety of thalidomide in children and young adults with intractable inflammatory bowel disease: long-term results, Aliment Pharmacol Ther, 25, 419, 10.1111/j.1365-2036.2006.03211.x

Baldassano, 2003, Infliximab (REMICADE) therapy in the treatment of pediatric Crohn's disease, Am J Gastroenterol, 98, 833, 10.1111/j.1572-0241.2003.07343.x

Hyams, 2007, Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children, Gastroenterology, 132, 863, 10.1053/j.gastro.2006.12.003

Hyams, 2000, Use of infliximab in the treatment of Crohn's disease in children and adolescents, J Pediatr, 137, 192, 10.1067/mpd.2000.107161

Kugathasan, 2000, Prolonged duration of response to infliximab in early but not late pediatric Crohn's disease, Am J Gastroenterol, 95, 3189, 10.1111/j.1572-0241.2000.03263.x

Lionetti, 2003, Response to infliximab is related to disease duration in paediatric Crohn's disease, Aliment Pharmacol Ther, 18, 425, 10.1046/j.1365-2036.2003.01672.x

Serrano, 2001, Use of infliximab in pediatric patients with inflammatory bowel disease, Ann Pharmacother, 35, 823, 10.1345/aph.10395

Stephens, 2003, Safety and steroid-sparing experience using infliximab for Crohn's disease at a pediatric inflammatory bowel disease center, Am J Gastroenterol, 98, 104, 10.1111/j.1572-0241.2003.07161.x

Cezard, 2003, A prospective study of the efficacy and tolerance of a chimeric antibody to tumor necrosis factors (Remicade) in severe pediatric Crohn's disease, J Pediatr Gastroenterol Nutr, 36, 632, 10.1097/00005176-200305000-00007

de Ridder, 2004, Infliximab therapy in 30 patients with refractory pediatric Crohn disease with and without fistulas in the Netherlands, J Pediatr Gastroenterol Nutr, 39, 46, 10.1097/00005176-200407000-00010

Lee, 2004, The use of infliximab in South-East Asian children with severe Crohn's disease, Pediatr Int, 46, 198, 10.1046/j.1442-200x.2004.01870.x

Wynands, 2008, 12-month follow-up after successful infliximab therapy in pediatric Crohn disease, J Pediatr Gastroenterol Nutr, 46, 293, 10.1097/MPG.0b013e31815604cd

de Ridder, 2008, Infliximab dependency in pediatric Crohn's disease: long-term follow-up of an unselected cohort, Inflamm Bowel Dis, 14, 353, 10.1002/ibd.20329

Borrelli, 2004, Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease, Dig Liver Dis, 36, 342, 10.1016/j.dld.2003.12.014

Walters, 2007, Linear growth improves during infliximab therapy in children with chronically active severe Crohn's disease, Inflamm Bowel Dis, 13, 424, 10.1002/ibd.20069

Lamireau, 2004, Efficacy and tolerance of infliximab in children and adolescents with Crohn's disease, Inflamm Bowel Dis., 10, 745, 10.1097/00054725-200411000-00008

Mian, 2005, Adalimumab, a novel anti-tumor necrosis factor-alpha antibody in a child with refractory Crohn's disease, J Pediatr Gastroenterol Nutr, 41, 357, 10.1097/01.mpg.0000169275.86308.b0

Miele, 2004, Human antichimeric antibody in children and young adults with inflammatory bowel disease receiving infliximab, J Pediatr Gastroenterol Nutr, 38, 502, 10.1097/00005176-200405000-00008

Vermeire, 2007, Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn's disease, Gut, 56, 1226, 10.1136/gut.2006.099978

Toruner, 2008, Risk factors for opportunistic infections in patients with inflammatory bowel disease, Gastroenterology, 134, 929, 10.1053/j.gastro.2008.01.012

Mackey, 2009, Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease: update, J Pediatr Gastroenterol Nutr, 48, 386, 10.1097/MPG.0b013e3181957a11

Singh Ranger, 2006, Surgery results in significant improvement in growth in children with Crohn's disease refractory to medical therapy, Pediatr Surg Int, 22, 347, 10.1007/s00383-006-1664-1

Lipson, 1990, Acceleration of linear growth following intestinal resection for Crohn disease, Eur J Pediatr, 149, 687, 10.1007/BF01959522

Griffiths, 1991, Factors influencing postoperative recurrence of Crohn's disease in childhood, Gut, 32, 491, 10.1136/gut.32.5.491

Besnard, 1998, Postoperative outcome of Crohn's disease in 30 children, Gut, 43, 634, 10.1136/gut.43.5.634

Sentongo, 2000, Growth after intestinal resection for Crohn's disease in children, adolescents, and young adults, Inflamm Bowel Dis, 6, 265, 10.1097/00054725-200011000-00001

Dokucu, 2002, Indications and results of surgery in patients with Crohn's disease with onset under 10years of age: a series of 18 patients, Eur J Pediatr Surg, 12, 180, 10.1055/s-2002-32725

van der Zaag-Loonen, 2004, Coping strategies and quality of life of adolescents with inflammatory bowel disease, Qual Life Res, 13, 1011, 10.1023/B:QURE.0000025598.89003.0c

Wilschanski, 1996, Supplementary enteral nutrition maintains remission in paediatric Crohn's disease, Gut, 38, 543, 10.1136/gut.38.4.543

Sylvester, 2007, Natural history of bone metabolism and bone mineral density in children with inflammatory bowel disease, Inflamm Bowel Dis, 13, 42, 10.1002/ibd.20006

Harpavat, 2005, Altered bone mass in children at diagnosis of Crohn's disease: a pilot study, J Pediatr Gastroenterol Nutr, 40, 295, 10.1097/01.MPG.0000153278.98861.32

Walthers, 2006, Osteoporosis in pediatric patients suffering from chronic inflammatory bowel disease with and without steroid treatment, J Pediatr Gastroenterol Nutr, 43, 42, 10.1097/01.mpg.0000228105.91240.80

Paganelli, 2007, Inflammation is the main determinat of low bone mineral density in pediatric inflammatory bowel disease, Inflamm Bowel Dis, 13, 416, 10.1002/ibd.20039

Gokhale, 1998, Bone mineral density assessment in children with inflammatory bowel disease, Gastroenterology, 114, 902, 10.1016/S0016-5085(98)70309-9

Boot, 1998, Bone mineral density and nutritional status in children with chronic inflammatory bowel disease, Gut, 42, 188, 10.1136/gut.42.2.188

Pappa, 2006, Report on the vitamin D status of adult and pediatric patients with inflammatory bowel disease and its significance for bone health and disease, Inflamm Bowel Dis, 12, 1162, 10.1097/01.mib.0000236929.74040.b0

Benchimol, 2007, Effect of calcium and vitamin D supplementation on bone mineral density in children with inflammatory bowel disease, J Pediatr Gastroenterol Nutr, 45, 538, 10.1097/MPG.0b013e3180dca0cc

Sawczenko, 2003, Variations in initial assessment and management of inflammatory bowel disease across Great Britain and Ireland, Arch Dis Child, 88, 990, 10.1136/adc.88.11.990

Baird, 1990, Increased risk of preterm birth for women with inflammatory bowel disease, Gastroenterology, 99, 987, 10.1016/0016-5085(90)90617-A

Khosla, 1984, Crohn's disease and pregnancy, Gut, 25, 52, 10.1136/gut.25.1.52

Woolfson, 1990, Crohn's disease and pregnancy, Dis Colon Rectum, 33, 869, 10.1007/BF02051924

Fonager, 1998, Pregnancy outcome for women with Crohn's disease: a follow-up study based on linkage between national registries, Am J Gastroenterol, 93, 2426, 10.1111/j.1572-0241.1998.00698.x

Baiocco, 1984, The influence of inflammatory bowel disease and its treatment on pregnancy and fetal outcome, J Clin Gastroenterol, 6, 211

Mayberry, 1986, European survey of fertility and pregnancy in women with Crohn's disease: a case control study by European collaborative group, Gut, 27, 821, 10.1136/gut.27.7.821

Hudson, 1997, Fertility and pregnancy in inflammatory bowel disease, Int J Gynaecol Obstet, 58, 229, 10.1016/S0020-7292(97)00088-X

Ording, 2002, Ulcerative colitis: female fecundity before diagnosis, during disease, and after surgery compared with a population sample, Gastroenterology, 122, 15, 10.1053/gast.2002.30345

Olsen, 1999, Fertility after ileal pouch-anal anastomosis in women with ulcerative colitis, Br J Surg, 86, 493, 10.1046/j.1365-2168.1999.01076.x

Oresland, 1994, Gynaecological and sexual function related to anatomical changes in the female pelvis after restorative proctocolectomy, Int J Colorectal Dis, 9, 77, 10.1007/BF00699417

Ravid, 2002, Pregnancy, delivery, and pouch function after ileal pouch-anal anastomosis for ulcerative colitis, Dis Colon Rectum, 45, 1283, 10.1007/s10350-004-6411-x

Tiainen, 1999, Ileal J-pouch-anal anastomosis, sexual dysfunction, and fertility, Scand J Gastroenterol, 34, 185, 10.1080/00365529950173069

Juhasz, 1995, Ileal pouch-anal anastomosis function following childbirth. An extended evaluation, Dis Colon Rectum, 38, 159, 10.1007/BF02052444

Damgaard, 1995, Social and sexual function following ileal pouch-anal anastomosis, Dis Colon Rectum, 38, 286, 10.1007/BF02055604

Johnson, 2001, Morbidity and functional outcome after restorative proctocolectomy for ulcerative colitis, Eur J Surg, 167, 40

Levi, 1979, Male infertility due to sulphasalazine, Lancet, 2, 276, 10.1016/S0140-6736(79)90292-7

Birnie, 1981, Incidence of sulphasalazine-induced male infertility, Gut, 22, 452, 10.1136/gut.22.6.452

O'Morain, 1984, Reversible male infertility due to sulphasalazine: studies in man and rat, Gut, 25, 1078, 10.1136/gut.25.10.1078

Toth, 1979, Reversible toxic effect of salicylazosulfapyridine on semen quality, Fertil Steril, 31, 538, 10.1016/S0015-0282(16)44000-8

Dejaco, 2001, Azathioprine treatment and male fertility in inflammatory bowel disease, Gastroenterology, 121, 1048, 10.1053/gast.2001.28692

Narendranathan, 1989, Male infertility in inflammatory bowel disease, J Clin Gastroenterol, 11, 403, 10.1097/00004836-198908000-00011

Mahadevan, 2005, Infliximab and semen quality in men with inflammatory bowel disease, Inflamm Bowel Dis, 11, 395, 10.1097/01.MIB.0000164023.10848.c4

Katz, 2004, Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis, Am J Gastroenterol, 99, 2385, 10.1111/j.1572-0241.2004.30186.x

Hanan, 1985, Inflammatory bowel disease in the pregnant woman, Clin Perinatol, 12, 669, 10.1016/S0095-5108(18)30862-5

Larzilliere, 1998, Chronic inflammatory bowel disease and pregnancy. Case control study, Gastroenterol Clin Biol, 22, 1056

Miller, 1986, Inflammatory bowel disease in pregnancy: a review, J R Soc Med, 79, 221, 10.1177/014107688607900410

Reddy, 2008, Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes, Am J Gastroenterol, 103, 1203, 10.1111/j.1572-0241.2007.01756.x

Baird, 1990, Increased risk of preterm birth for women with IBD, Gastroenterology, 99, 987, 10.1016/0016-5085(90)90617-A

Nielsen, 1984, Pregnancy in CD, Scand J Gastroenterol, 19, 724, 10.1080/00365521.1984.12005800

Mahadevan, 2007, Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study form northern California, Gastroenterology, 133, 1106, 10.1053/j.gastro.2007.07.019

Bortoli, 2007, Pregnancy before and after the diagnosis of inflammatory bowel diseases: retrospective case–control study, J Gastroenterol Hepatol, 22, 542, 10.1111/j.1440-1746.2006.04754.x

Cornish, 2007, A meta-analysis on the influence of inflammatory bowel disease on pregnancy, Gut, 56, 830, 10.1136/gut.2006.108324

Riis, 2006, Does pregnancy change the disease course? A study in a European cohort of patients with inflammatory bowel disease, Am J Gastroenterol, 101, 1539, 10.1111/j.1572-0241.2006.00602.x

Korelitz, 1998, Inflammatory bowel disease and pregnancy, Gastroenterol Clin North Am, 27, 213, 10.1016/S0889-8553(05)70354-X

Fedorkow, 1989, Inflammatory bowel disease: a controlled study of late pregnancy outcome, Am J Obstet Gynecol, 160, 998, 10.1016/0002-9378(89)90324-4

Mogadam, 1981, Pregnancy in inflammatory bowel disease: effect of sulfasalazine and corticosteroids on fetal outcome, Gastroenterology, 80, 72, 10.1016/0016-5085(81)90193-1

Alstead, 2002, Inflammatory bowel disease in pregnancy, Postgrad Med J, 78, 23, 10.1136/pmj.78.915.23

Castiglione, 1996, Effect of pregnancy on the clinical course of a cohort of women with inflammatory bowel disease, Ital J Gastroenterol, 28, 199

Nwokolo, 1994, Surgical resections in parous patients with distal ileal and colonic Crohn's disease, Gut, 35, 220, 10.1136/gut.35.2.220

Buyon, 1998, The effects of pregnancy on autoimmune diseases, J Leukoc Biol, 63, 281, 10.1002/jlb.63.3.281

Ilnyckyji, 1999, Perianal Crohn's disease and pregnancy: role of the mode of delivery, Am J Gastroenterol, 94, 3274, 10.1111/j.1572-0241.1999.01537.x

Hahnloser, 2004, Pregnancy and delivery before and after ileal pouch-anal anastomosis for inflammatory bowel disease: immediate and long term consequences and outcomes, Dis Colonl Rectum, 47, 1127, 10.1007/s10350-004-0569-0

Ramalingam, 2003, Pregnancy delivery and pouch function after ileal pouch-anal anastomosis for ulcerative colitis, Dis Colon Rectum, 46, 1267, 10.1007/s10350-004-6730-y

Remzi, 2005, Vaginal delivery after ileal pouch-anal anastomosis: a word of caution, Dis Colon Rectum, 48, 1691, 10.1007/s10350-005-0124-7

Polle, 2006, Effect of vaginal delivery on long term pouch function, Br J Surg, 93, 1394, 10.1002/bjs.5467

Nicholl, 1993, Stomas and pregnancy, Aust NZ J Obstet Gynaecol, 33, 322, 10.1111/j.1479-828X.1993.tb02099.x

Brandt, 1995, Results of a survey to evaluate whether vaginal delivery and episiotomy lead to perineal involvement in women with Crohn's disease, Am J Gastroenterol, 90, 1918

Ong, 2007, Mode of delivery and risk of feacal incontinence in women with or without inflammatory bowel disease: questionnaire survey, Inflamm Bowel Dis, 13, 1391, 10.1002/ibd.20208

Subhani, 1998, Review article: the management of inflammatory bowel disease during pregnancy, Aliment Pharmacol Ther, 12, 1039, 10.1046/j.1365-2036.1998.00420.x

Nielsen, 1984, Pregnancy in Crohn's disease, Scand J Gastroenterol, 19, 724, 10.1080/00365521.1984.12005800

Hill, 1997, Surgical treatment of acute manifestations of Crohn's disease during pregnancy, J R Soc Med, 90, 64, 10.1177/014107689709000203

Kane, 2003, Inflammatory bowel disease in pregnancy, Gastroenterol Clin North Am, 32, 323, 10.1016/S0889-8553(02)00068-7

Jarnerot, 1979, Sulphasalazine treatment during breast feeding, Scand J Gastroenterol, 14, 869, 10.3109/00365527909181418

Khan, 1979, Placental and mammary transfer of sulphasalazine, Br Med J, 2, 1553, 10.1136/bmj.2.6204.1553

Norgard, 2001, Population based case control study of the safety of sulfasalazine use during pregnancy, APT, 15, 483

Esbjorner, 1987, Sulphasalazine and sulphapyridine serum levels in children to mothers treated with sulphasalazine during pregnancy and lactation, Acta Paediatr Scand, 76, 137, 10.1111/j.1651-2227.1987.tb10430.x

Diav-Citrin, 1998, The safety of mesalamine in human pregnancy: a prospective controlled cohort study, Gastroenterology, 114, 23, 10.1016/S0016-5085(98)70628-6

Habal, 1993, Oral 5-aminosalicylic acid for inflammatory bowel disease in pregnancy: safety and clinical course, Gastroenterology, 105, 1057, 10.1016/0016-5085(93)90949-D

Marteau, 1994, Mesalazine during pregnancy, Lancet, 344, 1708, 10.1016/S0140-6736(94)90493-6

Marteau, 1998, Foetal outcome in women with inflammatory bowel disease treated during pregnancy with oral mesalazine microgranules, Aliment Pharmacol Ther, 12, 1101, 10.1046/j.1365-2036.1998.00417.x

Norgard, 2003, Birth outcome in women exposed to 5-aminosalicylic acid during pregnancy: a Danish cohort study, Gut, 52, 243, 10.1136/gut.52.2.243

Rahimi, 2008, Pregnancy ooutcome in women with IBD following exposure to 5-ASA drugs: a meta-analysis, Repro Toicol, 25, 271, 10.1016/j.reprotox.2007.11.010

Burtin, 1995, Safety of metronidazole in pregnancy: a meta-analysis, Am J Obstet Gynecol, 172, 525, 10.1016/0002-9378(95)90567-7

Shennan, 2006, A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study, BJOG, 113, 65, 10.1111/j.1471-0528.2005.00788.x

Loebstein, 1998, Pregnancy outcome following gestational exposure to fluoroquinolones: a multicenter prospective controlled study, Antimicrob Agents Chemother, 42, 1336, 10.1128/AAC.42.6.1336

Schaefer, 1996, Pregnancy outcome after prenatal quinolone exposure. Evaluation of a case registry of the European Network of Teratology Information Services (ENTIS), Eur J Obstet Gynecol Reprod Biol, 69, 83, 10.1016/0301-2115(95)02524-3

Nhum, 2006, Antibiotics use in pregnancy and lactation: what is and is not known about teratogenic and toxic risks, Obstet Gynecol, 107, 1120, 10.1097/01.AOG.0000216197.26783.b5

Czeizel, 2001, Augmentin treatment during pregnancy and the prevalence of congenital abnormalities: a population-based case–control teratologic study, Eur J Obstet Gynecol Reprod Biol, 97, 188, 10.1016/S0301-2115(00)00545-5

Brumfitt, 1973, Trimethoprim-sulfamethoxazole in the treatment of bacteriuria in women, J Infect Dis, 128

Park-Wylie, 2000, Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies, Teratology, 62, 385, 10.1002/1096-9926(200012)62:6<385::AID-TERA5>3.0.CO;2-Z

Nørgård, 2007, Disease activity in pregnant women with Crohn's disease and birth outcomes: a regional Danish cohort study, Am J Gastroenterol, 102, 1947, 10.1111/j.1572-0241.2007.01355.x

Koren, 1998, Drugs in pregnancy, N Engl J Med, 338, 1128, 10.1056/NEJM199804163381607

Ferrero, 2004, Inflammatory bowel disease: management issues during pregnancy, Arch Gynecol Obstet, 270, 79, 10.1007/s00404-003-0489-6

Norjavaara, 2003, Normal pregnancy outcomes in a population-based study including 2, 968 pregnant women exposed to budesonide, J Allergy Clin Immunol, 111, 736, 10.1067/mai.2003.1340

Kallen, 1999, Congenital malformations after the use of inhaled budesonide in early pregnancy, Obstet Gynecol, 93, 392, 10.1016/S0029-7844(98)00454-2

Beaulieu, 2009, Budesonide induction and maintenance therapy for Crohn's disease during pregnancy, Inflamm Bowel Dis, 15, 25, 10.1002/ibd.20640

Kihlstrom, 1987, Teratogenicity study of the new glucocorticosteroid budesonide in rabbits, Arzneimittelforschung, 37, 43

Bermas, 1995, Effects of immunosuppressive drugs during pregnancy, Arthritis Rheum, 38, 1722, 10.1002/art.1780381203

Roubenoff, 1988, Effects of antiinflammatory and immunosuppressive drugs on pregnancy and fertility, Semin Arthritis Rheum, 18, 88, 10.1016/0049-0172(88)90002-9

Willis, 2000, Children of renal transplant recipient mothers, J Paediatr Child Health, 36, 230, 10.1046/j.1440-1754.2000.00500.x

Blatt, 1980, Pregnancy outcome following cancer chemotherapy, Am J Med, 69, 828, 10.1016/S0002-9343(80)80007-6

Nicholson, 1968, Cytotoxic drugs in pregnancy. Review of reported cases, J Obstet Gynaecol Br Commonw, 75, 307, 10.1111/j.1471-0528.1968.tb02083.x

Platzek, 1996, Dose–response relationship of teratogenicity and prenatal-toxic risk estimation of 6-mercaptopurine riboside in mice, Teratog Carcinog Mutagen, 16, 169, 10.1002/(SICI)1520-6866(1996)16:3<169::AID-TCM3>3.0.CO;2-G

Mosesso, 1993, The genetic toxicology of 6-mercaptopurine, Mutat Res, 296, 279, 10.1016/0165-1110(93)90015-F

Alstead, 1990, Safety of azathioprine in pregnancy in inflammatory bowel disease, Gastroenterology, 99, 443, 10.1016/0016-5085(90)91027-4

Francella, 2003, The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study, Gastroenterology, 124, 9, 10.1053/gast.2003.50014

Norgard, 2003, Azathioprine, mercaptopurine and birth outcome: a population-based cohort study, Aliment Pharmacol Ther, 17, 827, 10.1046/j.1365-2036.2003.01537.x

Zlatanic, 2003, Complications of pregnancy and child development after cessation of treatment with 6-mercaptopurine for inflammatory bowel disease, J Clin Gastroenterol, 36, 303, 10.1097/00004836-200304000-00005

Dejaco, 2005, Pregnancy and birth outcome under thiopurine therapy for inflammatory bowel disease, Gastroenterology, 128, A-12

Rajapakse, 2000, Outcome of pregnancies when fathers are treated with 6-mercaptopurine for inflammatory bowel disease, Am J Gastroenterol, 95, 684, 10.1111/j.1572-0241.2000.01846.x

Bar, 2001, Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis, Transplantation, 71, 1051, 10.1097/00007890-200104270-00006

Armenti, 1994, National Transplantation Pregnancy Registry—outcomes of 154 pregnancies in cyclosporine-treated female kidney transplant recipients, Transplantation, 57, 502, 10.1097/00007890-199402270-00004

Radomski, 1995, Outcomes of 500 pregnancies in 335 female kidney, liver, and heart transplant recipients, Transplant Proc, 27, 1089

Bertschinger, 1995, Cyclosporine treatment of severe ulcerative colitis during pregnancy, Am J Gastroenterol, 90, 330

Branche, 2009, Cyclosporine treatment of steroid-refractory ulcerative colitis during pregnancy, Inflamm Bowel Dis, 15, 1044, 10.1002/ibd.20858

Kainz, 2000, Review of the course and outcome of 100 pregnancies in 84 women treated with tacrolimus, Transplantation, 70, 1718, 10.1097/00007890-200012270-00010

Kozlowski, 1990, Outcome of first-trimester exposure to low-dose methotrexate in eight patients with rheumatic disease, Am J Med, 88, 589, 10.1016/0002-9343(90)90522-F

Kane, 2002, Managing pregnancy in IBD, Inflamm Bowel Dis Monit, 4, 2

Vasiliauskas, 2006, Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn, Clin Gastroenterol Hepatol, 4, 1255, 10.1016/j.cgh.2006.07.018

Mahadevan, 2005, Intentional infliximab use during pregnancy for induction or maintenance of remission of Crohn's disease, Aliment Pharmacol Ther, 21, 733, 10.1111/j.1365-2036.2005.02405.x

Katz, 2004, Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis, Am J Gastroenterol, 99, 2385, 10.1111/j.1572-0241.2004.30186.x

Vesga, 2005, Adalimumab use in pregnancy, Gut, 54, 890, 10.1136/gut.2005.065417

Miskin, 2006, Succesful use of adalimumab for Crohn's disease in pregnancy, Inflamm Bowel Dis, 12, 827, 10.1097/00054725-200608000-00020

Coburn, 2006, The successful use of adalimumab to treat active Crohn's disease of an ileoanal pouch during pregnancy, Dig Dis Sci, 51, 2045, 10.1007/s10620-006-9452-2

Johnson, 2009, Pregnancy outcomes in women exposed to adalimumab: the OTIS autoimmune diseases in pregnancy project, Gastroenterology, 136, A-27, 10.1016/S0016-5085(09)60125-6

Calabrese, 2000, Thalidomide: current and potential clinical applications, Am J Med, 108, 487, 10.1016/S0002-9343(99)00408-8

Smithells, 1992, Recognition of thalidomide defects, J Med Genet, 29, 716, 10.1136/jmg.29.10.716

Pinder, 1976, Metoclopramide: a review of its pharmacological properties and clinical use, Drugs, 12, 81, 10.2165/00003495-197612020-00001

Sahakian, 1991, Vitamin B6 is effective therapy for nausea and vomiting of pregnancy: a randomized, double-blind placebo-controlled study, Obstet Gynecol, 78, 33

Siu, 2002, Treatment of intractable hyperemesis gravidarum by ondansetron, Eur J Obstet Gynecol Reprod Biol, 105, 73, 10.1016/S0301-2115(02)00116-1

Larson, 1997, Double-blind, placebo-controlled study of ranitidine for gastroesophageal reflux symptoms during pregnancy, Obstet Gynecol, 90, 83, 10.1016/S0029-7844(97)00126-9

Nikfar, 2002, Use of proton pump inhibitors during pregnancy and rates of major malformations: a meta-analysis, Dig Dis Sci, 47, 1526, 10.1023/A:1015863018105

Stuart, 1982, Effects of acetylsalicylic-acid ingestion on maternal and neonatal hemostasis, N Engl J Med, 307, 909, 10.1056/NEJM198210073071502

Kane, 2004, Fertility and pregnancy, 333

Baron, 1993, Gastrointestinal motility disorders during pregnancy, Ann Intern Med, 118, 366, 10.7326/0003-4819-118-5-199303010-00008

2001, Transfer of drugs and other chemicals into human milk, Paediatrics, 108, 776, 10.1542/peds.108.3.776

Heisterberg, 1983, Blood and milk concentration of metronidazole in mothers and infants, J Perinat Med, 11, 114, 10.1515/jpme.1983.11.2.114

Gardner, 1992, Simultaneous concentrations of ciprofloxacin in breast milk and in serum in mother and breast fed infant, Clin Pharm, 11, 352

Ost, 1985, Prednisolone excretion in human milk, J Pediatr, 106, 1008, 10.1016/S0022-3476(85)80259-6

Christensen, 2005, Excretion of azathioprine metabolites in maternal milk, Gut, 54, A-45

Gardiner, 2006, Exposure to thiopurines drugs through breast milk is low based on metabolite concentrations in mother infant pairs, Br J Clin Pharmacol, 62, 453, 10.1111/j.1365-2125.2006.02639.x

Moretti, 2006, Breast feeding during maternal use of azathioprine, Ann Pharmacother, 40, 2269, 10.1345/aph.1H152

Drossman, 1998, Presidential address: gastrointestinal illness and biopsychosocial model, Psychosom Med, 60, 258, 10.1097/00006842-199805000-00007

Rubin, 2004, Quality of life in patients with established inflammatory bowel disease: a UK general practice survey, Aliment Pharmacol Ther, 19, 529, 10.1111/j.1365-2036.2004.1873.x

Guthrie, 2002, Psychological disorder and severity of inflammatory bowel disease predict health-related quality of life in ulcerative colitis and Crohn's disease, Am J Gastroenterol, 97, 1994, 10.1111/j.1572-0241.2002.05842.x

Nordin, 2002, Health-related quality of life and psychological distress in a population-based sample of Swedish patients with inflammatory bowel disease, Scand J Gastroenterol, 37, 450, 10.1080/003655202317316097

Kurina, 2001, Depression and anxiety in people with inflammatory bowel disease, J Epidemiol Community Health, 55, 716, 10.1136/jech.55.10.716

Drossman, 1991, Health status and health care use in persons with inflammatory bowel disease. A national sample, Dig Dis Sci, 36, 1746, 10.1007/BF01296620

Helzer, 1984, A study of the association between Crohn's disease and psychiatric illness, Gastroenterology, 86, 324, 10.1016/0016-5085(84)90418-9

Casellas, 2001, Influence of inflammatory bowel disease on different dimensions of quality of life, Eur J Gastroenterol Hepatol, 13, 567, 10.1097/00042737-200105000-00017

Cohen, 2002, The quality of life in patients with Crohn's disease, Aliment Pharmacol Ther, 16, 1603, 10.1046/j.1365-2036.2002.01323.x

Guassora, 2000, Quality of life study in a regional group of patients with Crohn's disease. A structured interview study, Scand J Gastroenterol, 35, 1068, 10.1080/003655200451199

Addolorato, 1997, Inflammatory bowel disease: a study of the association between anxiety and depression, physical morbidity, and nutritional status, Scand J Gastroenterol, 32, 1013, 10.3109/00365529709011218

Porcelli, 1996, A prospective study of the relationship between disease activity and psychologic distress levels in patients with inflammatory bowel disease, Scand J Gastroenterol, 31, 792, 10.3109/00365529609010354

Li, 2004, Psychological stress and inflammatory bowel disease: a follow-up study in parents who lost a child in Denmark, Am J Gastroenterol, 99, 1129, 10.1111/j.1572-0241.2004.04155.x

Bernstein, 2009, Triggers of flares in IBD, Gastroenterology, 134, 1106

Mittermaier, 2004, Impact of depressive mood on relapse in patients with IBD: a prospective 18-month follow-up study, Psychosom Med, 66, 79, 10.1097/01.PSY.0000106907.24881.F2

Mardini, 2004, Crohn's disease: a two-year prospective study of the association between psychological distress and disease activity, Dig Dis Sci, 49, 492, 10.1023/B:DDAS.0000020509.23162.cc

Andrews, 1987, Psychiatric illness in patients with inflammatory bowel disease, Gut, 28, 1600, 10.1136/gut.28.12.1600

Vidal, 2008, Health-related quality of life in inflammatory bowel disease patients: the role of psychopathology and personality, Inflamm Bowel Dis, 14, 977, 10.1002/ibd.20388

Wietersheim, 1992, Relapse-precipitating life events and feelings in patients with inflammatory bowel disease, Psychother Psychosom, 58, 103, 10.1159/000288617

North, 1991, Do life events or depression exacerbate inflammatory bowel disease?, A prospective study. Ann Intern Medicine, 114, 381, 10.7326/0003-4819-114-5-381

Duffy, 1991, Relevance of major stress events as an indicator of disease activity prevalence in inflammatory bowel disease, Behav Med, 17, 101, 10.1080/08964289.1991.9937553

Bitton, 2008, Predicting relapse in Crohn's disease: a biopsychosocial model, Gut, 57, 1386, 10.1136/gut.2007.134817

Gomez-Gil, 2003, Relationship between patient's subjective stress perception and the course of inflammatory bowel disease, Gastroenterol Hepatol, 26, 411

Robertson, 1989, Personality profile and affective state of patients with inflammatory bowel disease, Gut, 30, 623, 10.1136/gut.30.5.623

Nigro, 2001, Psychiatric predictors of noncompliance in inflammatory bowel disease, J Clin Gastroenterol, 32, 66, 10.1097/00004836-200101000-00015

Sewitch, 2002, Psychosocial correlates of patient–physician discordance in inflammatory bowel disease, Am J Gastroenterol, 97, 2174, 10.1111/j.1572-0241.2002.05969.x

Wietersheim, 1999, Education of patients with inflammatory bowel diseases, Wien Med Wochenschr, 149, 352

Moser, 1995, Disease-related worries and concerns: a study on out-patients with inflammatory bowel disease, Eur J Gastroenterol Hepatol, 9, 853

Kennedy, 2003, A randomised controlled trial to assess the impact of a package comprising a patient-orientated, evidence-based self-help guidebook and patient-centred consultations on disease management and satisfaction in inflammatory bowel disease, Health Technol Assess, 7, iii1, 10.3310/hta7280

Kennedy, 2004, A randomised controlled trial to assess the effectiveness and cost of a patient orientated self management approach to chronic inflammatory bowel disease, Gut, 53, 1639, 10.1136/gut.2003.034256

Borgaonkar, 2002, Providing disease-related information worsens health-related quality of life in inflammatory bowel disease, Inflamm Bowel Dis, 8, 264, 10.1097/00054725-200207000-00005

Lange, 1996, Patient education in inflammatory bowel disease, Z Gastroenterol, 34, 411

Larsson, 2003, A group-based patient education programme for high-anxiety patients with Crohn disease or ulcerative colitis, Scand J Gastroenterol, 38, 763, 10.1080/00365520310003309

Sewitch, 2003, Patient nonadherence to medication in inflammatory bowel disease, Am J Gastroenterol, 98, 1535, 10.1111/j.1572-0241.2003.07522.x

Guyatt, 1989, A new measure of health status for clinical trials in inflammatory bowel disease, Gastroenterology, 96, 804, 10.1016/S0016-5085(89)80080-0

Irvine, 1996, The short inflammatory bowel disease questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease, Am J Gastroenterol, 91, 1571

Drossman, 1991, The rating form of IBD patient concerns: a new measure of health status, Psychosom Med, 53, 701, 10.1097/00006842-199111000-00010

Miehsler, 2004, Assessing the demand for psychological care in chronic diseases: development and validation of a questionnaire based on the example of inflammatory bowel disease, Inflamm Bowel Dis, 10, 637, 10.1097/00054725-200409000-00021

Moser, 2003, Psychosomatics [diagnostics and treatment of Crohn's disease — results of an evidence-based consensus conference of the German Society for Digestive and Metabolic Diseases], Z Gastroenterol, 41, 50, 10.1055/s-2003-36668

Moser, 2004, Psychosomatic [diagnosis and therapy of ulcerative colitis: results of an evidence-based consensus conference by the German Society of Digestive and Metabolic Diseases and the Competence Network on Inflammatory Bowel Disease], Z Gastroenterol, 42, 1038, 10.1055/s-2004-813517

Sewitch, 2001, Psychological distress, social support, and disease activity in patients with inflammatory bowel disease, Am J Gastroenterol, 96, 1470, 10.1111/j.1572-0241.2001.03800.x

Mussell, 2003, Reducing psychological distress in patients with inflammatory bowel disease by cognitive-behavioural treatment: exploratory study of effectiveness, Scand J Gastroenterol, 38, 755, 10.1080/00365520310003110

Schwarz, 1991, Evaluation of psychological treatment for inflammatory bowel disease, Behav Res Ther, 29, 167, 10.1016/0005-7967(91)90045-5

Milne, 1986, A stress management program for inflammatory bowel disease patients, J Advan Nurs, 11, 561, 10.1111/j.1365-2648.1986.tb01288.x

Deter, 2007, Psychological treatment may reduce the need for healthcare in patients with Crohn's disease, Inflamm Bowel Dis, 13, 745, 10.1002/ibd.20068

Jantschek, 1998, Effect of psychotherapy on the course of Crohn's disease. Results of the German prospective multicenter psychotherapy treatment study on Crohn's disease. German Study Group on Psychosocial Intervention in Crohn's Disease, Scand J Gastroenterol, 33, 1289, 10.1080/00365529850172386

Keller, 2004, J Psychosom Res, 56, 687, 10.1016/S0022-3999(03)00122-3

Garcia-Vega, 2004, A stress management programme for Crohn's disease, Behav Res Ther, 42, 367, 10.1016/S0005-7967(03)00146-3

Maunder, 2001, Supportive–expressive group psychotherapy for persons with inflammatory bowel disease, Can J Psychiatry, 46, 622, 10.1177/070674370104600706

Su, 2002, Extraintestinal manifestations of inflammatory bowel disease, Gastroenterol Clin North Am, 31, 307, 10.1016/S0889-8553(01)00019-X

Barreiro-de Acosta, 2007, Relationship between clinical features of Crohn's disease and the risk of developing extraintestinal manifestations, Eur J Gastroenterol Hepatol, 19, 73, 10.1097/01.meg.0000243883.47938.aa

Orchard, 1998, Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history, Gut, 42, 387, 10.1136/gut.42.3.387

De Vlam, 2000, Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association, J Rheumatol, 27, 2860

Fornaciari, 2001, Musculoskeletal manifestations in inflammatory bowel disease, Can J Gastroenterol, 15, 399, 10.1155/2001/612531

Queiro, 2000, Subclinical sacroiliitis in inflammatory bowel disease: a clinical and follow up study, Clin Rheumatol, 19, 445, 10.1007/s100670070003

Steer, 2003, Low back pain, sacroiliitis, and the relationship with HLA-B27 in Crohn's disease, J Rheumatol, 30, 518

Peeters, 2008, Clinical and genetic factors associated with sacroilliitis in Crohn's disease, J Gastroenterol Hepatol, 23, 132, 10.1111/j.1440-1746.2007.05108.x

Van der Linden, 1984, Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of New York criteria, Arthritis Rheum, 27, 361, 10.1002/art.1780270401

Puhakka, 2004, MRI abnormalities of sacroiliac joints in early spondylarthropathy: a 1-year follow-up study, Scand J Rheumatol, 33, 332, 10.1080/03009740410005881

Braun, 2004, Analysing chronic spinal changes in ankylosing spondylitis: a systematic comparison of conventional X rays with magnetic resonance imaging using established and new scoring systems, Ann Rheum Dis, 63, 1046, 10.1136/ard.2003.019968

Ferraz, 1990, Meta-analysis of sulfasalazine in ankylosing spondylitis, J Rheumatol, 17, 1482

Palm, 2002, Prevalence of ankylosing spondylitis and other spondyloarthropathies among patients with inflammatory bowel disease: a population study (IBSEN study), J Rheumatol, 29, 511

Orchard, 2009, The prevalence, clinical features and association of HLA-B27 in sacroiliitis associated with established Crohn's disease, Aliment Pharmacol Ther, 29, 193, 10.1111/j.1365-2036.2008.03868.x

Van den Bosch, 2000, Crohn's disease associated with spondyloarthropathy: effect of TNFalpha blockade with infliximab on articular symptoms, Lancet, 356, 1821, 10.1016/S0140-6736(00)03239-6

Generini, 2004, Infliximab in spondyloarthropathy associated with Crohn's disease: a open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations, Ann Rheum Dis, 63, 1664, 10.1136/ard.2003.012450

Marzo-Orega, 2003, Efficacy of etanercept for treatment of Crohn's related spondyloarthritis but not colitis, Ann Rheum Dis, 62, 74, 10.1136/ard.62.1.74

Herfarth, 2002, Improvement of arthritis and arthralgia after treatment with infliximab in a German prospective open-label multicenter trial in refractory Crohn's disease, Am J Gastroenterol, 97, 2688, 10.1111/j.1572-0241.2002.06064.x

Cipolla, 2002, Nonsteroidal anti-inflammatory drugs and inflammatory bowel disease: current perspectives, Pharmacol Res, 46, 1, 10.1016/S1043-6618(02)00033-6

Evans, 1997, Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease, Gut, 40, 619, 10.1136/gut.40.5.619

Felder, 2000, Effects of nonsteroidal anti-inflammatory drugs on inflammatory bowel disease: a case control study, Am J Gastroenterol, 95, 1949, 10.1111/j.1572-0241.2000.02262.x

Bonner, 2004, A long-term cohort study of non-steroidal antiinflammatory drug use and disease activity in outpatients with inflammatory bowel diseases, IBD, 10, 751

El Miedany, 2006, The gastrointestinal safety and effect on disease activity of etoricoxib, a selective COX-2 inhibitor in inflammatory bowel diseases, Am J Gastroenterol, 101, 311, 10.1111/j.1572-0241.2006.00384.x

Sandborn, 2006, Safety of celecoxib in patients with ulcerative colitis in remission: a randomised placebo controlled pilot study, Clin Gastroenterol Hepatol, 4, 203, 10.1016/j.cgh.2005.12.002

Dougados, 1995, Sulfasalazine in the treatment of spondyloarthropathy. A randomised multicenter, double-blind placebo controlled study, Arthritis Rheum, 38, 618, 10.1002/art.1780380507

Clegg, 1996, Comparison of sulfasalazine and placebo in treatment of ankylosing spondylitis, Arthritis Rheum, 39, 2004, 10.1002/art.1780391209

Van Den Bosch, 2002, Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondyloarthropathy, Arthritis Rheum, 46, 755, 10.1002/art.511

Zochling, 2006, Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis, Ann Rheum Dis, 65, 423, 10.1136/ard.2005.041129

Braun, 2002, Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial, Lancet, 359, 1187, 10.1016/S0140-6736(02)08215-6

Gorman, 2002, Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha, N Engl J Med, 346, 1349, 10.1056/NEJMoa012664

Van der Heijde, 2005, Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized placebo-controlled trial (ASSERT), Arthritis Rheum, 52, 582, 10.1002/art.20852

Van der Heijde, 2006, Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a randomized placebo-controlled trial, Arthritis Rheum, 54, 2136, 10.1002/art.21913

Lambert, 2007, Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis; a multicenter randomized, double-blind placebo controlled trial, Arthritis Rheum, 56, 4005, 10.1002/art.23044

Braun, 2008, Persistent clinical efficacy and safety of anti-TNF therapy with infliximab in patients with ankylosing spondylitis over 5years: evidence for different type of respons, Ann Rheum Dis, 67, 340, 10.1136/ard.2007.075879

Reinshagen, 2008, Osteoporosis in inflammatory bowel disease, Journal of Crohn's and Colitis, 2, 202, 10.1016/j.crohns.2008.01.005

Wahner, 1989, Technical aspects and clinical interpretation of bone mineral measurements, Public Health Rep, 104, 27

Siffledeen, 2007, Vertebral fractures and role of low bone mineral density in Crohn's disease, Clin Gastroenterol Hepatol, 5, 721, 10.1016/j.cgh.2007.02.024

Klaus, 2002, High prevalence of osteoporotic vertebral fractures in patients with Crohn's disease, Gut, 51, 654, 10.1136/gut.51.5.654

Stockbrugger, 2002, Discordance between the degree of osteopenia and the prevalence of spontaneous vertebral fractures in Crohn's disease, Aliment Pharmacol Ther, 16, 1519, 10.1046/j.1365-2036.2002.01317.x

Black, 2001, An assessment tool for predicting fracture risk in postmenopausal women, Osteoporos Int, 12, 519, 10.1007/s001980170072

Bischoff-Ferrari, 2005, Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials, JAMA, 293, 2257, 10.1001/jama.293.18.2257

Reffitt, 2003, Bone density improves with disease remission in patients with inflammatory bowel disease, Eur J Gastroenterol Hepatol, 15, 1267, 10.1097/00042737-200312000-00003

Trost, 2005, Important cutaneous manifestations of inflammatory bowel disease, Postgrad Med J, 81, 580, 10.1136/pgmj.2004.031633

Requena, 2007, Erythema nodosum, Semin Cutan Med Surg, 26, 114, 10.1016/j.sder.2007.02.009

Freeman, 2005, Erytherma nodosum and pyoderma gangrenosum in 50 patietns with Crohn's disease, Can J Gastroenterol, 19, 603, 10.1155/2005/323914

Nguyen, 2006, Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanics Whites: characterization of a large North American cohort, Am J Gastroenterol, 101, 1012, 10.1111/j.1572-0241.2006.00504.x

Barreiro-de Acosta, 2007, Relationship between clinical features of Crohn's disease and the risk of developing extraintestinal manifestations, Eur J Gastroenterol Hepatol, 19, 73, 10.1097/01.meg.0000243883.47938.aa

Emanuel, 2008, Metastatic Crohn's disease: a histopathologic study of 12 cases, J Cutan Pathol, 35, 457, 10.1111/j.1600-0560.2007.00849.x

Orchard, 2002, Uveitis and erythema nodosum in inflammatory bowel disease: clinical features and the role of HLA genes, Gastroenterology, 123, 714, 10.1053/gast.2002.35396

Clayton, 2006, Treatment of chronic erythema nodosum with infliximab, Clin Exp Dermatol, 31, 823, 10.1111/j.1365-2230.2006.02221.x

Callen, 2007, Pyoderma gangrenosum: an update, Rheum Dis Clin North Am, 33, 787, 10.1016/j.rdc.2007.07.016

Menachem, 2004, Clinical manifestations of pyoderma gangrenosum associated with inflammatory bowel disease, Isr Med Assoc J, 6, 88

Weenig, 2002, Skin ulcers misdiagnosed as pyoderma gangrenosum, N Engl J Med, 347, 1412, 10.1056/NEJMoa013383

Brooklyn, 2006, Diagnosis and treatment of pyoderma gangrenosum, BMJ, 333, 181, 10.1136/bmj.333.7560.181

Juillerat, 2007, Extraintestinal manifestations of Crohn's disease, Digestion, 76, 141, 10.1159/000111029

Matis, 1992, Treatment of pyoderma gangrenosum with cyclosporine, Arch Dermatol, 128, 1060, 10.1001/archderm.1992.01680180054005

Ljung, 2002, Pyoderma gangrenosum associated with Crohn disease:effects of TNF-a blockade with infliximab, Scand J Gastroenterol, 37, 1108, 10.1080/003655202320378338

Regueiro, 2003, Infliximab for the treatment of pyoderma gangrenosum associated with inflammatory bowel disease, Am J Gastroenterol, 98, 1821, 10.1111/j.1572-0241.2003.07581.x

Brooklyn, 2006, Infliximab for the treatment of pyoderma gangrenosum: a randomised, double-blind, placebo controlled trial, Gut, 55, 505, 10.1136/gut.2005.074815

Poritz, 2008, Management of peristomal pyoderma gangrenosum, J Am Coll Surg, 206, 311, 10.1016/j.jamcollsurg.2007.07.023

Cohen, 2007, Sweet's syndrome — a comprehensive review of an acute febrile neutrophilic dermatosis, Orphanet J Rare Dis, 2, 34, 10.1186/1750-1172-2-34

Travis, 1997, Sweet's syndrome: an unusual cutaneous manifestation of Crohn's disease and ulcerative colitis, Eur J Gastroenterol Hepatol, 9, 715, 10.1097/00042737-199707000-00013

Ytting, 2005, Sweet's syndrome — an extraintestinal manifestation in inflammatory bowel disease, Digestion, 72, 195, 10.1159/000088466

Mintz, 2004, Ocular manifestations of inflammatory bowel disease, Inflamm Bowel Dis, 10, 135, 10.1097/00054725-200403000-00012

Vitellas, 2002, Comparison of MR cholangiopancreatographic techniques with contrast-enhanced cholangiography in the evaluation of sclerosing cholangitis, Am J Roentgenol, 178, 327, 10.2214/ajr.178.2.1780327

Talwalkar, 2004, Cost-minimization analysis of MRC versus ERCP for the diagnosis of primary sclerosing cholangitis, Hepatology, 40, 39, 10.1002/hep.20287

Cullen, 2006, The medical management of primary sclerosing cholangitis, Semin Liver Dis, 26, 52, 10.1055/s-2006-933563

Lindor, 1997, Ursodiol for primary sclerosing cholangitis, N Eng J Med, 336, 691, 10.1056/NEJM199703063361003

Mitchell, 2001, A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis, Gastroenterology, 121, 900, 10.1053/gast.2001.27965

Sjoqvist, 2004, Ursodeoxycholic acid treatment in IBD-patients with colorectal dysplasia and/or DNA-aneuploidy: a prospective, double-blind, randomized controlled pilot study, Anticancer Res, 24, 3121

Van Thiel, 1995, Tacrolimus, a treatment for primary sclerosing cholangitis: results of an open label preliminary trial, Am J Gastroenterol, 90, 455

Bernstein, 2001, The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study, Thromb Haemost, 85, 430, 10.1055/s-0037-1615600

Miehsler, 2004, Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?, Gut, 53, 542, 10.1136/gut.2003.025411

Bernstein, 2007, Hospitalization-based major comorbidity of inflammatory bowel disease in Canada, Can J Gastroenterol, 21, 507, 10.1155/2007/924257

Nguyen, 2008, Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients, Am J Gastroenterol, 103, 1

Danese, 2007, Inflammation and coagulation in inflammatory bowel disease: the clot thickens, Am J Gastroenterol, 102, 174, 10.1111/j.1572-0241.2006.00943.x

2000, Guidelines on diagnosis and management of acute pulmonary embolism, Eur Heart J, 21, 1301, 10.1053/euhj.2000.2250

Qaseem, 2007, Current diagnosis of venous thromboembolism in primary care: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians, Ann Intern Med, 146, 454, 10.7326/0003-4819-146-6-200703200-00013

Kearon, 2008, Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians evidence-based clinical practice guideline (8th edition), Chest, 133, 454, 10.1378/chest.08-0658

2006, Prevention and treatment of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence), Int Angiol, 25, 101

Shen, 2007, Meta-analysis: the utility and safety of heparin in the treatment of acitve ulcerative colitis, Aliment Pharmacol Ther, 26, 653, 10.1111/j.1365-2036.2007.03418.x

Geerts, 2008, Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition), Chest, 133, 353, 10.1378/chest.08-0656

Dentali, 2007, Meta-analysis: anticoagulant prophylaxis to prevent symtomatic venous thromboemblism in hospitalized medical patients, Ann Int Med, 146, 278, 10.7326/0003-4819-146-4-200702200-00007

Samama, 1999, A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients, N Engl J Med, 341, 793, 10.1056/NEJM199909093411103

Alikhan, 2004, Risk factors for venous thromboemblism in hospitalized patients with acute medical illness, Arch Intern Med, 164, 963, 10.1001/archinte.164.9.963

Hilsden, 2003, Complementary and alternative medicine use by Canadian patients with inflammatory bowel disease: results from a national survey, Am J Gastroenterol, 98, 1563, 10.1111/j.1572-0241.2003.07519.x

Langhorst, 2005, Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease: results from a German national survey, Inflamm Bowel Dis, 11, 287, 10.1097/01.MIB.0000160771.71328.6c

Burgmann, 2004, Predictors of alternative and complementary medicine use in inflammatory bowel disease: do measures of conventional health care utilization relate to use?, Am J Gastroenterol, 99, 889, 10.1111/j.1572-0241.2004.30033.x

Dick, 2003, Use of unlicensed and off-label medications in paediatric gastroenterology with a review of the commonly used formularies in the UK, Aliment Pharmacol Ther, 17, 571, 10.1046/j.1365-2036.2003.01441.x

Langmead, 2006, Review article: complementary and alternative therapies for inflammatory bowel disease, Aliment Pharmacol Ther, 23, 341, 10.1111/j.1365-2036.2006.02761.x

Gerhardt, 2001, Therapy of active Crohn disease with Boswellia serrata extract H 15, Z Gastroenterol, 39, 11, 10.1055/s-2001-10708

Joos, 2006, Acupuncture and moxibustion in the treatment of ulcerative colitis: a randomized controlled study, Scand J Gastroenterol, 41, 1056, 10.1080/00365520600580688

Joos, 2004, Acupuncture and moxibustion in the treatment of active Crohn's disease: a randomized controlled study, Digestion, 69, 131, 10.1159/000078151

Belluzzi, 1996, Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease, N Engl J Med, 334, 1557, 10.1056/NEJM199606133342401

Feagan, 2008, Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC randomized controlled trials, JAMA, 299, 1690, 10.1001/jama.299.14.1690

Turner, 2009, Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease, Cochrane Database Syst Rev, 1, CD006320